Business Globalization Pharmaceutical 
CIO
NOVEMBER 22, 2024
The road ahead for IT leaders in turning the promise of generative AI into business value remains steep and daunting, but the key components of the gen AI roadmap — data, platform, and skills — are evolving and becoming better defined. That was the key takeaway from the “What’s Next for GenAI in Business” panel at last week’s Big.AI@MIT
CIO
AUGUST 1, 2022
With more than 30,000 employees spread across more than 60 affiliate locations and 14 manufacturing sites around the world, pharmaceutical company Eli Lilly operates at a truly global scale. Operating at that scale comes with issues, not the least of which is sharing accurate and timely information internally and externally.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CIO
MARCH 2, 2023
By virtue of their position between IT and effecting business strategy, CIOs can identify what processes their organizations need in order to modernize and automate. That’s not surprising since CIOs typically own IT automation, as well as help drive business automation.
CIO
JULY 30, 2024
Many of the AI use cases entrenched in business today use older, more established forms of AI, such as machine learning, or don’t take advantage of the “generative” capabilities of AI to generate text, pictures, and other data. Business process augmentation Generative AI is finding a sweet spot in enterprise business process augmentation.
CIO
SEPTEMBER 30, 2024
Moreover, 64% of those IT decision-makers expect AI and machine learning to significantly alter the way their business operates over the next three to five years, up from 39% who said the same in 2023. Such statistics don’t tell the whole story, though, says Beatriz Sanz Sáiz, EY’s global consulting data and AI leader.
CIO
MARCH 24, 2023
Perhaps most important, Idorsia taps into Veeva’s evolving knowledge base, which encompasses data from other customers such as major pharmaceuticals giants Merck, Bayer, and Kronos, the CIO says. And that is a major gain for a startup — getting the know-how and experience of Veeva’s entire customer base, he says.
CIO
JUNE 13, 2024
After the creation of Towa International in 2020 as part of the acquisition process of Pensa Pharma by Japan-based parent company Towa Pharmaceutical, Remuzgo decided to deconstruct the conception of the IT function, and rebuild it. “A The objective was to consolidate functions and become a new player in the pharmaceutical industry.
Expert insights. Personalized for you.
510 
Let's personalize your content